featured
Efficacy and Safety of Apixaban in Patients Following Cardioversion for AtrialFibrillation: Insights From the ARISTOTLE Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology